- Home
- MLAB vs LYEL Comparison
MLAB vs LYEL Comparison
Compare MLAB & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLAB | LYEL |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.0M | 490.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MLAB | LYEL |
|---|---|---|
| Price | $81.75 | $20.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $94.00 | $27.25 |
| AVG Volume (30 Days) | ★ 114.2K | 83.6K |
| Earning Date | 02-03-2026 | 03-12-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | ★ $36,000.00 |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | $17,438.13 |
| P/E Ratio | $42.87 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $59.63 | $0.39 |
| 52 Week High | $128.55 | $45.00 |
Technical Indicators
Market Signals| Indicator | MLAB | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 41.48 |
| Support Level | $69.73 | $15.82 |
| Resistance Level | $81.62 | $27.30 |
| Average True Range (ATR) | 3.70 | 2.18 |
| MACD | 0.04 | -0.20 |
| Stochastic Oscillator | 61.88 | 29.74 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.